设为首页 加入收藏

TOP

Cavan- Alpha Kit Tablets/Softgels
2016-07-26 09:40:01 来源: 作者: 【 】 浏览:374次 评论:0
  • SPL UNCLASSIFIED SECTION

    Tablets/Softgels

    Rx Only

  • DESCRIPTION

    Cavan™- Alpha Kit is a prescription prenatal/postnatal multivitamin/mineral tablet and a softgel with an essential fatty acid.

    Each tablet has the following active Ingredient:

    Folic Acid 1 mg

    Each tablet also contains the following ingredients for nutritional supplementation:

    Vitamin A (beta carotene) 3,000 IU
    Vitamin C (ascorbic acid) 120 mg
    Vitamin D (cholecalciferol) 800 IU
    Vitamin E (dl-alpha tocopheryl acetate) 3 mg
    Vitamin B1 (thiamine mononitrate) 1.8 mg
    Vitamin B2 (riboflavin) 4 mg
    Niacinamide 20 mg
    Vitamin B6 (pyridoxine hydrochloride) 50 mg
    Vitamin B12 (cyanocobalamin) 12 mcg
    Calcium (calcium carbonate) 230 mg
    Iron (polysaccharide iron complex and
    sodium iron EDTA)
    27 mg
    Magnesium (magnesium oxide) 25 mg
    Zinc (zinc oxide) 25 mg
    Copper (cupric oxide) 2 mg
    Iodine 220 mcg

    Each softgel contains the following ingredients for nutritional supplementation:

    Total omega-3 long chain fatty acids at least 300 mg*
    As DHA 200 mg**
    As other omega-3 long-chain fatty acids 100 mg**
    * from at least 429 mg of purified fish oil.
    ** approximately.

    Inactive Ingredients (tablet): Ascorbyl Palmitate, Citric Acid, Croscarmellose Sodium, Ethyl Cellulose, FD&C Blue #1, FD&C Yellow #5, Fumed Silica, Gum Arabic, Hydroxypropyl Cellulose, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Polyethylene Glycol, Polysorbate 80, PVP K30, Stearic Acid, Talc, Titanium Dioxide, TriPotassium Citrate, Vegetable Oil.

    Inactive Ingredients (softgel): Acetyl a ted Monoglycerides, Ethyl Vanillin, Gelatin, Glycerin, Polysorbate 80, Potassium Sorb ate, Purified Water, Shellac Ammonium Salt, Sodium Alginate, Specially Denatured Alcohol, Stearic Acid, Vitamin E.

  • INDICATIONS AND USAGE

    Cavan™-Alpha Kit is indicated for the supplemental requirements of patients with nutritional deficiencies or are in need of nutritional supplementation.

  • CONTRAINDICATIONS

    This product is contraindicated in patients with a known hypersensitivity to any of the ingredients, including fish and fish oil.

  • WARNING

    Daily ingestion of more than 3 g per day of omega-3 fatty acids (ALA. EPA, and DHA) from fish oils may have potential antithrombotic activities, or effects, and may increase bleeding times. Administration of omega-3 fatty acids-including DHA, should be avoided in patients with inherited or acquired bleeding diatheses, including those taking anticoagulants.

  • SPL UNCLASSIFIED SECTION

    This product contains fish oil.

  • PRECAUTIONS

    General: Folic acid, when administered as a single agent in doses above 0.1 mg daily, may obscure the detection of B12 deficiency {specifically, the administration of folic acid may reverse the hematological manifestations of B12 deficiency, including pernicious anemia, while not addressing the neurological manifestations). Reduced folates may be less likely than folic acid to mask vitamin B12 deficiency. Folate therapy alone is Inadequate for the treatment of B12 deficiency.

  • PATIENT INFORMATION

    Cavan™- Alpha Kit is a prescription vitamin for use only under the direction and supervision of a licensed physician.

  • INTERACTIONS

    Pyridoxine hydrochloride should not be given to patients receiving the drug levodopa, because the action of levodopa is antagonized by pyridoxine hydrochloride. However, pyridoxine hydrochloride may be used concurrently in patients receiving a preparation containing both carbidopa and levodopa.

    Drugs which may interact with folate include:

    • Anti epileptic drugs (AED): The AED class including, but not limited to, phenytoin, carbamazepine, primidone, valproic acid, phenobarbital and lamotrigine have been shown to impair folate absorption and increase the metabolism of circulating folate. Additionally, concurrent use of folic acid has been associated with enhanced phenytoin metabolism, lowering the level of this AED in the blood and allowing breakthrough seizures to occur.
    • Capecitabine: Folinic acid (5-formyltetrahydrofolate) may increase the toxicity of Capecitabine.
    • Cholestyramlne: Reduces folic acid absorption and reduces serum folate levels.
    • Colestipol: Reduces folic acid absorption and reduces serum folate levels.
    • Cycloserine: Reduces folic acid absorption and reduces serum folate levels.
    • Dihydrofolate Reductase Inhibitors (DHFRI): DHFRIs block the conversion of folic acid to its active forms, and lower plasma and red blood cell folate levels. DHFRls include aminopterin, methotrexate, pyrimethamine, triamterene, and trimethoprim.
    • Fluoxetine: Fluoxetine exerts a noncompetitive inhibition of the 5-methyltetrahydrofolate active transport in the intestine.
    • lsotretinoin: Reduced folate levels have occurred in some patients taking isotretinoin.
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): NSAIDs have been shown to inhibit some folate dependent enzymes in laboratory experiments. NSAIDs include ibuprofen, naproxen, indomethacin and sulindac.
    • Oral Contraceptives: Serum folate levels may be depressed by oral contraceptive therapy.
    • Methylprednisolone: Reduced serum folate levels have been noted after treatment with methylprednisolone.
    • Pancreatic Enzymes: Reduced folate levels have occurred in some patients taking pancreatic extracts.
    • Pentamidine: Reduced folate levels have been seen with prolonged intravenous pentamidine.
    • Smoking and Alcohol: Reduced serum folate levels have been noted.
    • Sulfasalazine: Inhibits the absorption and metabolism of folic acid.
    • Metformin treatment in patients with type 2 diabetes decreases serum folate.
    • Warfarin can produce Significant impairment In folate status after a 6-month therapy.
  • ADVERSE REACTIONS

    Allergic sensitization has been reported following both oral and parenteral administration of folic acid, as well as possibly the use of other forms of folates - including reduced folates. Paresthesia, somnolence, nausea and headaches have been reported with pyridoxine hydrochloride. Mild transient diarrhea, polycythemia vera, itching, transitory exanthema and the feeling of swelling of the entire body have been associated with cyanocobalamin.

  • DOSAGE AND ADMINISTRATION

    One tablet and one softgel daily with or without food, or as prescribed by a licensed health care provider with prescribing auth

  • HOW SUPPLIED

    Cavan™- Alpha Kit is supplied in child-resistant blister packs of 30 tablets and 30 softgels. The Cavan™- Alpha Kit tablet is an oval, yellow tablet with "S127" debossed on one side. The Cavan™- Alpha Kit softgel is an enteric-coated oblong, clear softgel.

    NDC 13925-127-10

    STORAGE

    Store at controlled room temperature 20-25°C (68-77°F). Protect from moisture and excessive heat. Note that contact with moisture may produce surface discoloration of the tablet.

    Call your doctor about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.

    Rx Only

    Reserved for Professional Recommendation

    All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under a physician's supervision. There are no implied or explicit claims on therapeutic equivalence.

    Manufactured For:
    Seton Pharmaceuticals
    Manasquan, NJ 08736
    1-800-510-3401

    MADE IN CANADA

    06/11

    SETON

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    NDC 13925-127-10

    Cavan™- Alpha Kit

    Tablets / Softgels

    R x Only

    30-Day Supply
    30 Tablets / 30 Softgels

    SETON PHARMACEUTICALS

    Carton Label
  • INGREDIENTS AND APPEARANCE
    CAVAN ALPHA  beta carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium carbonate, iron, magnesium oxide, zinc oxide, cupric oxide, iodine, omega-3 fatty acids kit
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:13925-127
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:13925-127-10 1 in 1 BLISTER PACK    
    Quantity of Parts
    Part # Package Quantity Total Product Quantity
    Part 1 1 BLISTER PACK 30 
    Part 2 1 BLISTER PACK 30 
    Part 1 of 2
    CAVAN ALPHA  beta carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium carbonate, iron, magnesium oxide, zinc oxide, cupric oxide, iodine tablet
    Product Information
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BETA CAROTENE (UNII: 01YAE03M7J) (BETA CAROTENE - UNII:01YAE03M7J) BETA CAROTENE 3000 [iU]
    ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID 120 mg
    CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL 800 [iU]
    .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) (ALPHA-TOCOPHEROL - UNII:H4N855PNZ1) ALPHA-TOCOPHEROL 3 mg
    THIAMINE MONONITRATE (UNII: 8K0I04919X) (THIAMINE - UNII:X66NSO3N35) THIAMINE 1.8 mg
    RIBOFLAVIN (UNII: TLM2976OFR) (RIBOFLAVIN - UNII:TLM2976OFR) RIBOFLAVIN 4 mg
    NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE 20 mg
    PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE 50 mg
    CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204) CYANOCOBALAMIN 12 ug
    CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM - UNII:SY7Q814VUP) CALCIUM 230 mg
    IRON (UNII: E1UOL152H7) (IRON - UNII:E1UOL152H7) IRON 27 mg
    MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM - UNII:I38ZP9992A) MAGNESIUM 25 mg
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC - UNII:J41CSQ7QDS) ZINC 25 mg
    CUPRIC OXIDE (UNII: V1XJQ704R4) (COPPER - UNII:789U1901C5) COPPER 2 mg
    IODINE (UNII: 9679TC07X4) (IODINE - UNII:9679TC07X4) IODINE 220 ug
    FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID 1 mg
    Inactive Ingredients
    Ingredient Name Strength
    ASCORBYL PALMITATE (UNII: QN83US2B0N)  
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    ETHYLCELLULOSES (UNII: 7Z8S9VYZ4B)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    FD&C YELLOW NO. 5 (UNII: I753WB2F1M)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    ACACIA (UNII: 5C5403N26O)  
    HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    POLYETHYLENE GLYCOL (UNII: 3WJQ0SDW1A)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    POVIDONE K30 (UNII: U725QWY32X)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    TALC (UNII: 7SEV7J4R1U)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    POTASSIUM CITRATE ANHYDROUS (UNII: 86R1NVR0HW)  
    CORN OIL (UNII: 8470G57WFM)  
    Product Characteristics
    Color yellow (Clear) Score no score
    Shape OVAL (OVAL) Size 19mm
    Flavor   Imprint Code S127
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1   30 in 1 BLISTER PACK    
     
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    unapproved drug other   07/01/2010  
    Part 2 of 2
    CAVAN ALPHA  omega-3 fatty acids capsule, liquid filled
    Product Information
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    OMEGA-3 FATTY ACIDS (UNII: 71M78END5S) (OMEGA-3 FATTY ACIDS - UNII:71M78END5S) OMEGA-3 FATTY ACIDS 300 mg
    Inactive Ingredients
    Ingredient Name Strength
    DIACETYLATED MONOGLYCERIDES (UNII: 5Z17386USF)  
    ETHYL VANILLIN (UNII: YC9ST449YJ)  
    GELATIN (UNII: 2G86QN327L)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    WATER (UNII: 059QF0KO0R)  
    SHELLAC (UNII: 46N107B71O)  
    SODIUM ALGINATE (UNII: C269C4G2ZQ)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    ALCOHOL (UNII: 3K9958V90M)  
    ALPHA-TOCOPHEROL (UNII: H4N855PNZ1)  
    Product Characteristics
    Color yellow (clear) Score no score
    Shape CAPSULE (oblong) Size 8mm
    Flavor   Imprint Code  
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1   30 in 1 BLISTER PACK    
     
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    unapproved drug other   07/01/2010  
     
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    unapproved drug other   07/01/2010  
    Labeler - Seton Pharmaceuticals (828898002)
    Establishment
    Name Address ID/FEI Business Operations
    VIVA   253288898 MANUFACTURE
    Establishment
    Name Address ID/FEI Business Operations
    Rainbow Gold   800695152 REPACK 
  • 以下是“全球医药”详细资料
    Tags: 责任编辑:admin
    】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
    分享到QQ空间
    分享到: 
    上一篇Vitamin K1 Injection (Phytonadi.. 下一篇IC-GREEN (indocyanine green for..

    相关栏目

    最新文章

    图片主题

    热门文章

    推荐文章

    相关文章

    广告位